Oral semaglutide proves effective for type 2 diabetes and weight loss in Dutch study

FHS
June 18, 2024
11:43 pm

A recent study from the PIONEER REAL Netherlands trial demonstrated that oral semaglutide effectively manages type 2 diabetes and supports weight loss in adults.

Study explores parents’ struggle with children’s avid eating behaviors

Study investigates parental experiences and challenges in feeding preschoolers with avid eating behavior, highlighting strategies to foster healthy eating habits and prevent obesity.

April 24, 2024

Abiomed announces enrollment of first patient in landmark RECOVER IV trial for AMI cardiogenic shock

Abiomed, part of Johnson & Johnson MedTech, announces the first patient in the world has been enrolled in the landmark RECOVER IV randomized controlled trial

November 27, 2023

‘Ancient DNA’ tools and 23andMe database uncover African American ancestries of thousands

New research that combines technology to sequence “ancient DNA” with direct-to-consumer genetic testing has identified tens of thousands people alive today who are genetically linked

August 3, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.